25例支架内血栓患者的长期随访The long-term follow-up of Major adverse cardiac events (MACE) in patients with stent thrombosis
张鹤萍,陈晖,严松彪,赵慧强,李虹伟
摘要(Abstract):
目的随访支架内血栓患者的心血管事件及临床预后。方法对2000年3月至2009年12月在北京友谊医院行经皮冠状动脉介入术(PCI)患者(3854例)中,因剧烈胸痛再次入院诊断为急性心肌梗死并经冠状动脉造影证实为支架内血栓形成的25例患者进行长期随访,观察其临床心脏事件(MACE)。结果支架内血栓患者25例,男21例,女4例,平均年龄为(59·5±12·8)岁,其中亚急性血栓8例、晚期血栓3例、极晚期血栓14例。支架内血栓形成后的平均随访时间为(864±775)d。随访期间急性心肌梗死5例,其中4例患者为原支架内再次血栓形成(均为药物涂层支架),1例患者为血栓靶血管出现新的狭窄;靶病变血管重建4例;靶血管重建1例;左心室收缩功能障碍4例(射血分数EF<30%,3例为药物涂层支架)。25例患者均存活出院。结论支架内血栓患者发生严重临床心脏事件的概率很高,远期随访问题应值得高度重视。
关键词(KeyWords): 血管成形术,经腔,经皮冠状动脉;冠状动脉血栓形成
基金项目(Foundation):
作者(Author): 张鹤萍,陈晖,严松彪,赵慧强,李虹伟
参考文献(References):
- [1]Kuchulakanti PK,Chu WW,Torguson R,et al.Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus-and paclitaxel-eluting stents.Circulation,2006,113:1108-1113.
- [2]Trabattoni D,Fabbiocchi F,Montorsi P,et al.Stent thrombosis after sirolimus-and paclitaxel-eluting stent implantation in daily clinical practice:analysis of a single center registry.Catheter Cardiovasc Interv,2007,70:415-421.
- [3]Cutlip DE,Windecker S,Mehran R,et al.Clinical end points in coronary stent trials:a case for standardized definitions.Circulation,2007,115:2344-2351.
- [4]Kereiakes DN,Choo JK,Young JJ,et al.Thrombosis and drug-eluting stents:a critical appraisal.Rev Cardiovasc Med,2004,5:9-15.
- [5]Wang F,Stouffer GA,Waxman S,et al.Late coronary stent thrombosis:early vs.late stent thrombosis in the stent era.Catheter Cardiovasc Interv,2002,55:142-147.
- [6]Mauri L,Hsieh WH,Massaro JM,et al.Stent thrombosis in randomized clinical trials of drug-eluting stents.N Engl J Med,2007,356:1020-1029.
- [7]Wernick MH,Jeremias A,Carrozza JP.Drug-eluting stents and stent thrombosis:a cause for concern Coron Artery Dis,2006,17:661-665.
- [8]Pfisterer M,Brunner-La Rocca HP,Buser PT,et al.Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents:an observational study of drug-eluting versus bare-metal stents.J Am Coll Cardiol,2006,48:2584-2591.